28 days Prescribing information Lente human insulin (rDNA origin) zinc suspension Humulin L (Lilly) 28 days Prescribing information Insulin lispro (rDNA origin) vial Humalog vial (Lilly ...
Interesting Engineering on MSN4d
FDA approves first-ever rapid-acting insulin biosimilar for diabetes treatmentThe FDA has approved Merilog, the first-ever rapid-acting insulin biosimilar for diabetes treatment that helps manage blood ...
Insulin lispro protamine suspension 75% (rDNA origin), insulin lispro 25% (rDNA ... has been shown to be equipotent to Regular human insulin on a molar basis. Instruct patients on diet, exercise ...
Insulin isophane suspension (NPH) 70% (human, rDNA origin), regular insulin 30% (human, rDNA origin) 100 Units/mL; susp for SC inj. Instruct patients on proper administration of insulin ...
Hosted on MSN1mon
How Richard DiMarchi Revolutionized Diabetes TreatmentHumalog, an injectable, fast-acting insulin to treat diabetes, became the first rDNA-derived molecule chemically optimized for human use. What has been his formula for success in leading drug ...
Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.
Human growth hormone (hGH ... In contrast, only two rDNA products, insulin glulisine (Apidra; Sanofi-Aventis, Strasbourg, France) and the fertility drug, lutropin alfa (Luveris; Serono, Geneva ...
Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback